Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CTLA4 anticorps

Cet anticorps anti-CTLA4 est un anticorps Lapin Chimeric détectant CTLA4 dans IF et BR. Adapté pour Souris.
N° du produit ABIN7072467

Aperçu rapide pour Recombinant CTLA4 anticorps (ABIN7072467)

Antigène

Voir toutes CTLA4 Anticorps
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 130
  • 86
  • 44
  • 14
  • 3
Souris

Hôte

  • 73
  • 72
  • 24
  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 114
  • 67
  • 2
Chimeric

Conjugué

  • 85
  • 19
  • 13
  • 13
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CTLA4 est non-conjugé

Application

  • 99
  • 70
  • 62
  • 38
  • 28
  • 19
  • 17
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunofluorescence (IF), Blocking Reagent (BR)

Clone

9D9
  • Fonction

    Anti-CTLA-4 [9D9], Rabbit IgG, kappa

    Specificité

    The antibody is specific for CTLA-4.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Purification

    Protein A affinity purified

    Immunogène

    The antibody was raised against CTLA-4.

    Isotype

    IgG kappa
  • Indications d'application

    The antibody has been used to block CTLA-4 and has been shown to enhance T-cell immunity against tumours (Quezada et al, 2006). 9D9 also has an anti-B16/BL6 melanoma effect in non-irradiated tumour-bearing recipients when given as combinatorial therapy with Gvax (Peggs et al, 2009). Selby et al. (PMID: 24777248) show how conversion of the original mouse IgG2b to a mouse IgG2a greatly increases anti-tumor activity of the 9D9 antibody in both MC38 (C57BL/6 mice) and CT26 (BALB/c mice) models. This mechanism both involves blockade of CTLA4 as well as depletion of tumor-infiltrating regulatory T-cells. Fc Silent antibodies were shown to have reduced anti-tumor activity as they did not deplete tumor infiltrating regulatory T-cells, however they lead to expansion of peripheral Tregs.

    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Autre désignation

    CTLA-4

    Sujet

    CD152, CTLA4, Cytotoxic T-Lymphocyte Associated Protein 4, Insulin-Dependent Diabetes Mellitus 12, Celiac Disease 3, Ligand And Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Fo

    UniProt

    P09793

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!